Key Facts

Background
  • Legacy Pharmaceuticals International purchased the Basel Switzerland and Humacao Puerto Rico sites and selected brands from Valeant Pharmaceuticals International in May 2007.
  • Until 2003, Valeant Pharmaceuticals International was known as ICN Pharmaceuticals, Inc.
  • ICN acquired the Basel site in 2000 with its purchase of  Solco Basel AG. The site was established by Solco in 1947.
  • ICN acquired the Puerto Rico site in 1997 from Roche. The site was established in 1973 and has benefited from significant ongoing investments and expansion since that time.
Employees 
  • Humacao, Puerto Rico - 200 employees
  • Basel, Switzerland - 200 employees
Investors 

Legacy is a privately held Company, with the majority owned by management.

 
Legacy's Contract Manufacturing Customers
 
These include large global pharmaceutical companies as well as specialty pharmaceuticals customers. 
 
 
 
 
 
 

 

© 2008 Legacy Pharmaceuticals International          
Site Map